163 related articles for article (PubMed ID: 30614088)
1. Insulin-like growth factor-II mRNA-binding protein 3 immunocytochemical expression in direct endometrial brushings: Possible diagnostic help in endometrial cytology.
Norimatsu Y; Yanoh K; Maeda Y; Irino S; Hirai Y; Fulciniti F; Kobayashi TK
Cytopathology; 2019 Mar; 30(2):215-222. PubMed ID: 30614088
[TBL] [Abstract][Full Text] [Related]
2. Nuclear morphometry as an adjunct to cytopathologic examination of endometrial brushings on LBC samples: A prospective approach to combined evaluation in endometrial neoplasms and look alikes.
Norimatsu Y; Irino S; Maeda Y; Yanoh K; Kurokawa T; Hirai Y; Kobayashi TK; Fulciniti F
Cytopathology; 2021 Jan; 32(1):65-74. PubMed ID: 32794283
[TBL] [Abstract][Full Text] [Related]
3. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
4. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
Li C; Zota V; Woda BA; Rock KL; Fraire AE; Jiang Z; Lu D; Xu B; Dresser K; Lutman CV; Fischer AH
Mod Pathol; 2007 Dec; 20(12):1263-8. PubMed ID: 17885673
[TBL] [Abstract][Full Text] [Related]
5. ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases.
Mhawech-Fauceglia P; Yan L; Liu S; Pejovic T
Histopathology; 2013 Jun; 62(7):976-85. PubMed ID: 23570281
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of notch-1 immunocytochemistry in endometrial cytology.
Mori M; Miyamoto T; Ohno S; Miyake Y; Sakaguchi T; Ohno E
Acta Cytol; 2012; 56(2):166-70. PubMed ID: 22378079
[TBL] [Abstract][Full Text] [Related]
7. Nuclear features in endometrial cytology: comparison of endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.
Norimatsu Y; Shigematsu Y; Sakamoto S; Ohsaki H; Yanoh K; Kawanishi N; Kobayashi TK
Diagn Cytopathol; 2012 Dec; 40(12):1077-82. PubMed ID: 22241733
[TBL] [Abstract][Full Text] [Related]
8. The immunohistochemical profile of atypical eosinophilic syncytial changes vs serous carcinoma.
Haley SL; Malhotra RK; Qiu S; Eltorky ME
Ann Diagn Pathol; 2011 Dec; 15(6):402-6. PubMed ID: 21855381
[TBL] [Abstract][Full Text] [Related]
9. IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.
Mhawech-Fauceglia P; Herrmann FR; Rai H; Tchabo N; Lele S; Izevbaye I; Odunsi K; Cheney RT
Am J Clin Pathol; 2010 Jun; 133(6):899-908. PubMed ID: 20472848
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
11. Cytological features of cervical smears in serous adenocarcinoma of the endometrium.
Todo Y; Minobe S; Okamoto K; Takeda M; Ebina Y; Watari H; Terashima M; Kaneuchi M; Yamamoto R; Sakuragi N
Jpn J Clin Oncol; 2003 Dec; 33(12):636-41. PubMed ID: 14769842
[TBL] [Abstract][Full Text] [Related]
12. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation-induced expression of S100A4 in endometrial carcinoma.
Xie R; Loose DS; Shipley GL; Xie S; Bassett RL; Broaddus RR
Mod Pathol; 2007 Oct; 20(10):1045-54. PubMed ID: 17673926
[TBL] [Abstract][Full Text] [Related]
14. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
[TBL] [Abstract][Full Text] [Related]
16. Squash cytodiagnosis of synchronous papillary serous carcinoma of ovary and endometrium with demonstration of serous tubal intraepithelial carcinoma as a precursor lesion.
Kar A; Kar T; Dha I; Panda S
Indian J Pathol Microbiol; 2017; 60(1):125-127. PubMed ID: 28195111
[No Abstract] [Full Text] [Related]
17. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
Yasuda M
J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
[TBL] [Abstract][Full Text] [Related]
18. Morphometrical Differences among Endometrial Endometrioid Carcinoma Grade 1, Grade 3, and Serous Carcinoma in Endometrial Liquid-Based Cytology Preparations.
Odashima H; Yoshioka H; Minami K; Miyakawa K; Horie K; Norimatsu Y; Yanoh K; Watanabe J
Acta Cytol; 2022; 66(6):524-531. PubMed ID: 36096095
[TBL] [Abstract][Full Text] [Related]
19. Expression of immunoreactivity and genetic mutation in eosinophilic and ciliated metaplastic changes of endometrial glandular and stromal breakdown: cytodiagnostic implications.
Shimizu K; Norimatsu Y; Kobayashi TK; Sakurai M; Ogura S; Yoshizawa A; Miyamoto T; Miyake Y; Aratake Y; Sakaguchi T; Ohno E
Ann Diagn Pathol; 2009 Apr; 13(2):89-95. PubMed ID: 19302956
[TBL] [Abstract][Full Text] [Related]
20. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
Alkushi A; Köbel M; Kalloger SE; Gilks CB
Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]